38
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Time Course Profile and Cell-Type-Specific Production of Monokine Induced by Interferon-γ in Concanavalin A-Induced Hepatic Injury in Mice: Comparative Study with Interferon-Inducible Protein-10

Pages 1344-1351 | Published online: 08 Jul 2009

  • Tiegs G, Hentschel J, Wendel A. A T cell-dependent experimental liver injury in mice inducible by Concanavalin A. J Clin Invest 1992;90:196-203.
  • Mizuhara H, O'Neill E, Seki N, Ogawa T, Kusunoki C, Otsuka K, et al. T cell activation-associated hepatic injury: mediation by tumor necrosis factors and protection by interleukin 6. J Exp Med 1994;179:1529-37.
  • Gantner F, Leist M, Lhose AW, Germann PG, Tiegs G. Concanavalin A-induced T cell- mediated hepatic injury in mice: the role of tumor necrosis factor. Hepatology 1995;21:190-8.
  • Ksontini R, Colagiovanni DB, Josephs MD, Edwards CK III, Tannahill CL, Solorzano CC, et al. Disparate roles for TNFa and Fas ligand in Concanavalin A-induced hepatitis. J Immunol 1998;160:4082-9.
  • Mizuhara H, Uno M, Seki N, Yamashha M, Yamaoka M, Ogawa T, et al. Critical involvement of interferon gamma in the pathogenesis of T-cell activation-associated hepatitis and regulatory mechanisms of interleukin-6 for the manifestations of hepatitis. Hepatology 1996;23:1608-15.
  • Tagawa Y, Sekikawa K, Iwakura Y. Suppression of Concanavalin A-induced hepatitis in IFN?-/- mice, but not in TNFa-/-mice. J Immunol 1997;159:1418-28.
  • Seino K, Kayagaki N, Takeda K, Fukao K, Okumura K, Yagita H. Contribution of Fas ligand to T cell-mediated hepatic injury in mice. Gastroenterology 1997;113:1315-22.
  • Tagawa Y, Kakuta S, Iwakura Y. Involvement of Fas/Fas ligand system-mediated apoptosis in the development of Concanavalin A-induced hepatitis. Eur J Immunol 1997;28:4105-13.
  • Watanabe Y, Morita M, Akaike T. Concanavalin A induces perforin-mediated but not Fas-mediated hepatic injury. Hepatology 1996;24:702-10.
  • Toyabe S, Seki S, Iiai T, Takeda K, Shirai K, Watanabe H, et al. Requirement of IL-4 and liver NK1+ T cells for Concanavalin A-induced hepatic injury in mice. J Immunol 1997;159:1537-42.
  • Kaneko Y, Harada M, Kawano T, Yamashha M, Shibata Y, Gejyo F, et al. Augmentation of Va14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of Concanavalin A-induced hepatitis. J Exp Med 2000;191:105-14.
  • Tagawa Y, Matthys P, Heremans H, Dillen C, Zaman Z, Iwakura Y, et al. Bimodal role of endogenous interleukin-6 in Concanavalin A-induced hepatitis in mice. J Leukoc Biol 2000; 67:90-6.
  • Luster AD. Chemokines--chemotactic cytokines that mediate inflammation. N Engl J Med 1998;338:436-45.
  • Adams DH, Lloyd AR. Chemokines: leucocyte recruitment and activation cytokines. Lancet 1997;349:490-5.
  • Loetscher M, Gerber B, Loetscher P, Jones SA, Piali L, Clark-Lewis I, et al. Chemokine receptor specific for IP-10 and Mig: structure, function, and expression in activated T-lymphocytes. J Exp Med 1996;184:963-9.
  • Tamaru M, Tominaga Y, Yatsunami K, Narumi S. Cloning of the murine interferon-inducible protein 10 (IP-10) receptor and its specific expression in lymphoid organs. Biochem Biophys Res Commun 1998;251:41-8.
  • Taub DD, Lloyd AR, Conlon K, Wang JM, Ortaldo JR, Harada A, et al. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med 1993; 177:1809-14.
  • Piali L, Weber C, LaRosa G, Mackay CR, Springer TA, Clark-Lewis I, et al. The chemokine receptor CXCR3 mediates rapid and shear-resistant adhesion-induction of effector T lymphocytes by the chemokine IP-10 and Mig. Eur J Immunol 1998; 28:961-72.
  • Luster AD, Greenberg SM, Leder P. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med 1995;182:219-31.
  • Angiolillo AL, Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, et al. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med 1995;182: 155-62.
  • Stricter RM, Polverini PJ, Kunkel SL, Arenberg DA, Burdick MD, Kasper J, et al. The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J Biol Chem 1995;270: 27348-57.
  • Luster AD, Leder P. IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo. J Exp Med 1993;178:1057-65.
  • Tannenbaum CS, Tubbs R, Armstrong D, Finke JH, Bukowski RM, Hamilton TA. The CXC chemokine s IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. J Immunol 1998;161:927-32.
  • Mahalingam S, Farber JM, Karupiah G. The interferon-inducible chemokines muMig and CRG-2 exhibit anti-viral activity in vivo. J Virol 1999;73:1479-91.
  • Narumi S, Wyner LM, Stoler MH, Tannenbaum CS, Hamilton TA. Tissue-specific expression of murine IP-10 mRNA following systemic treatment with interferon-?. J Leukoc Biol 1992;52: 27-33.
  • Ohmori Y, Wyner L, Narumi S, Armstrong D, Stoler M, Hamilton TA. Tumor necrosis factor-a induces cell type and tissue-specific expression of chemoattractant cytokines in vivo. Am J Pathol 1993;142:861-70.
  • Tamaru M, Nishioji K, Kobayashi Y, Watanabe Y, Itoh Y, Okanoue T, et al. Liver-infiltrating T lymphocytes are attracted selectively by IFN-inducible protein-10. Cytokine 2000;12:299-308.
  • Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987;162:156-9.
  • Farber JM. A macrophage mRNA selectively induced by ?-interferon encodes a member of the platelet factor 4 family of cytokines. Proc Natl Acad Sci USA 1987;87:5238-42.
  • Vanguri P, Farber JM. Identification of CRG-2; an interferon-inducible mRNA predicted to encode a murine monokine. J Biol Chem 1990;265:15049-57.
  • Maichuk D, Drumm M, Saulino A, Collins FS. Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products. Nucleic Acids Res 1990;19:1154.
  • Matsuura T, Kawada M, Hasumura S, Nagamori S, Obata T, Yamaguchi M, et al. High density culture of immortalized liver endothelial cells in the radial-flow bioreactor in the development of an artificial liver. Int J Artif Organs 1998;21:229-34.
  • Matsuura T, Kawada M, Sujino H. Vitamin A metabolism of immortalized hepatic stellate cells in the bioreactor. In: Wisse E, Knook DL, de Zanger, Fraser R, editors. Cells of the hepatic sinusoid. Vol. 7. Leiden, The Netherlands : Kupffer Cell Foundation, 1999: p. 88-9.
  • Narumi S, Yoneyama H, Inadera H, Nishioji K, Itoh Y, Okanoue T, et al. TNFa is a potent inducer for IFN-inducible protein-10 in hepatocytes and unaffected by GM-CSF in vivo, in contrast to IL-1ß and IFN-?. Cytokine 2000;12:1007-16.
  • Amichay D, Gazzinelli RT, Karupiah G, Moench TR, Sher A, Farber JM. Genes for chemokines MuMig and Crg-2 are induced in protozoan and viral infections in response to IFN-? with patterns of tissue expression that suggest nonredundant roles in vivo. J Immunol 1996;157:4511-20.
  • Widney DP, Xia Y-R, Lusis AJ, Smith JB. The murine chemokine CXCL11 (IFN-inducible T cell a chemoattractant) is an IFN-?- and lipopolysaccharide-inducible glucocorticoid -attenuated response gene expressed in lung and other tissues during endotoxemia. J Immunol 2000;164:6322-31.
  • Ohmori Y, Wyner L, Narumi S, Armstrong D, Stoler M, Hamilton DA. Tumor necrosis factor-a induces cell type and tissue-specific expression of chemoattractant cytokines in vivo. Am J Pathol 1993;142:861-9.
  • Yoneyama H, Harada A, Imai T, Babab M, Yoshie O, Zhang Y, et al. Pivotal role of TARC, a CC chemokine, in bacteria-induced fulminant hepatic failure in mice. J Clin Invest 1998; 102:1933-41.
  • Sauty A, Dziejman M, Taha RA, Iarossi AS, Neote K, Garcia-Zepeda EA, et al. The T cell-specific CXC chemokine IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells. J Immunol 1999;162:3549-58.
  • Mach F, Sauty A, Iarossi AS, Sukhova GK, Neote K, Libby P, et al. Differential expression of three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J Clin Invest 1999;104:1041-50.
  • Yoong KF, Afford SC, Jones R, Aujla P, Qin S, Price K, et al. Expression and function of CXC and CC chemokines in human malignant liver tumors: a role for human monokine induced by ?-interferon in lymphocyte recruitment to hepatocellular carcinoma. Hepatology 1999;30:100-11.
  • Narumi S, Tominaga Y, Tamaru M, Shimai S, Okumura H, Nishioji K, et al. Expression of IFN-inducible protein-10 in chronic hepatitis. J Immunol 1997;158:5536-44.
  • Yoshioka K, Kakumu S, Arao M, Tsutsumi Y, Inoue M. Tumor necrosis factor alpha production of peripheral blood mononuclear cells of patients with chronic liver disease. Hepatology 1989;10:769-73.
  • Itoh Y, Okanoue T, Enjyo F, Morimoto M, Takeuchi T, Kagawa K, et al. Elevated interleukin-6 and gamma-globulin during interferon therapy of hepatitis B. Am J Gastroenterol 1992;87: 1485-7.
  • Wang H, Gao X, Fukumoto S, Tademoto S, Sato K, Hirai K. Differential expression and regulation of chemokines JE, KC, and IP-10 gene in primary cultured murine hepatocytes. J Cell Physiol 1999;181:361-70.
  • Shields PL, Morland CM, Salmon M, Qin S, Hubscher SG, Adams DH. Chemokine and chemokine receptor interactions provide a mechanism for selective T cell recruitment to specific liver compartments within hepatitis C-infected liver. J Immunol 1999;163:6236-43.
  • Marra F, DeFranco R, Grappone C, Milani S, Pastacaldi S, Pinzani M, et al. Fibrogenesis: correlation with monocyte infiltration. Am J Pathol 1998;152:423-30.
  • Mather JJ, Lozier JS, Scott MK. Rat hepatic stellate cells produce cytokine-induced neutrophil chemoattractant in culture and in vivo. Am J Physiol 1998;275:G847-853.
  • Meyer M, Erdel M, Duba HC, Werner ER, Werner-Felmayer G. Cloning, genomic sequence, and chromosome mapping of scyb11, the murine homologue of SCYB11 (alias betaR1/ H174/SCYB9B/I-TAC/IP-9/CXCL11). Cytogenet Cell Genet 2000;88:278-82.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.